Update on non-alcoholic fatty liver disease in children

Clinical Nutrition

Volumn 26, Issue 4, 2007, Pages 409-415

  Papandreou, Dimitrios ^a   Rousso, Israel ^a   Mavromichalis, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Children; Liver disease; Non alcoholic fatty liver; Obesity; Steatohepatitis

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETAINE; FIBRIC ACID DERIVATIVE; INSULIN SENSITIZING AGENT; OMEGA 3 FATTY ACID; URSODEOXYCHOLIC ACID;

CHILDHOOD DISEASE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; EXERCISE; HEPATITIS; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MONOTHERAPY; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOGENESIS; PREVALENCE; REVIEW; STAGING; WEIGHT REDUCTION;

CHILD; DIAGNOSIS, DIFFERENTIAL; EXERCISE; FATTY LIVER; HUMANS; INSULIN RESISTANCE; OBESITY; PUBLIC HEALTH; SEVERITY OF ILLNESS INDEX; WEIGHT LOSS;

EID: 34447633011     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2007.02.002     Document Type: Review

References (61)

1. Loria P., Lonardo A., Carruli L., et al. Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 22 2 (2005) 31-36
2. Neuschawander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37 (2003) 1202-1219
3. Strauss R.S., Barlow S.E., and Dietz W.H. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 136 (2000) 727-733
4. Schwimmer B.J., Deutsch R., Kahen T., Lavine E.J., Stanley C., and Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 118 (2006) 1388-1393
5. Park H.S., Han J.H., Choi K.M., et al. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 82 (2005) 1046-1051
6. Tominaga K., Kurata J.H., Chen Y.K., et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Digest Dis Sci 40 (1995) 2002-2009
7. Sartorio A., Del Col A., Agosti F., et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 6 (2006)
8. Guzzalonni G., Grugni G., Minocci A., et al. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes Relat Metab Disord 24 (2000) 772-776
9. Vajro P., Fontanella A., Perna C., Orso G., Tedesco M., and De Vincenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 125 (1994) 239-241
10. Franzese A., Vajro P., Argenziano A., et al. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow up in an Italian population. Digest Dis Sci 42 (1997) 1428-1432
11. Bergomi A., Lughetti L., and Corciulo N. Italian multicenter study on liver damage in pediatric obesity. Int J Obes Relat Metab Disord 22 (1998) S22
12. Papandreou D., Rousso I., Bouzouki V., et al. Is non-alcoholic fatty liver disease in obese children associated with lipid profile and anthropometric measurments?. e-SPEN, Eur e-J Clin Nutr Metab 1 (2006) 239
13. Chan D.F., Li A.M., Chu W.C., et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 28 10 (2004) 1257-1263
14. Fu J.F., Liang L., Wang C.L., Hong F., Dong G.P., and Li Y. Nonalcoholic steatohepatitis in obese children: the prevalence and possible mechanism. Zhejiang Da Xue Xue Bao Yi Xue Ban 35 1 (2006) 64-68
15. Zou C.C., Liang L., Hong F., Fu J.F., and Zhao Z.Y. Serum adiponectin, resistin levels and non-alcoholic fatty liver disease in obese children. Endocr J 52 5 (2005) 519-524
16. Tazawa Y., Noguchi H., Nishinomiya F., and Takada G. Serum alanine aminotransferase activity in obese children. Acta Pediatr 86 (1997) 238-241
17. Kinugasa A., Tsunamoto K., Furukawa N., Sawada T., Kusunoki T., and Shimida N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr 3 (1984) 408-414
18. Kawasaki T., Hashimoto N., Kikuchi T., et al. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastrenterol Nutr 24 (1997) 317-321
19. Louthan M.V., Theriot J.A., Zimmerman E., Stutts J.T., and McClain C.J. Decreased prevalence of nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenderol Nutr 41 4 (2005) 426-429
20. Schwimmer J.B., McGreal N., Deutsch R., Finegold M.J., and Lavine J.E. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 115 (2005) e561-e565
21. Flores-Calderon J., Gomez-Diaz R.A., Rodriguez-Gomez G., and Moran-Villota S. Frequency of increased aminotransferases levels and associated metabolic abnormalities in obese and overweight children of an elementary school in Mexico City. Ann Hepatol 4 4 (2005) 279-283
22. Baldridge A.D., Perez-Atayde A.R., Graeme-Cook F., Higgins L., and Lavine J.E. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J Pediatr 127 5 (1995) 700-704
23. Schwimmer J.B., Deutsch R., Rauch J.B., Behling C., Newbury R., and Lavine J.E. Obesity, insulin resistance, and other clinicopathogical correlations of pediatric nonalcoholic fatty liver disease. J Pediatr 143 (2003) 500-505
24. Schwimmer J.B., McGreal N., Deutsch R., Finegold M.J., and Lvine J.E. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 126 (2004) T1093
25. Schwimmer J.B., Behling C., Newbury R., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42 (2005) 641-649
26. Samuel V.T., Liu Z.X., Qu X., et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 279 (2004) 32345-32353
27. Schattenberg J.M., Wang Y., Singh R., Rigoli R.M., and Czaja M.J. Hepatocyte CYP2E1 over expression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem 280 (2005) 9887-9894
28. Adams L.A., and Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet Med 22 (2005) 1129-1133
29. Chitturi S., and Farrell G.C. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 21 (2001) 27-41
30. Pessayre D., and Fromenty B. NASH: a mitochondrial disease. J Hepatol 42 (2005) 928-940
31. Le T.H., Caldwell S.H., Redick J.A., et al. The zonal distribution of megamitochondria with crystalline inclusions in nonalcoholic steatohepatitis. Hepatology 39 (2004) 1423-1429
32. Albano E., Mottaran E., Vidali M., et al. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54 (2005) 987-993
33. Bugianesi E., McCullough A.J., and Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42 (2005) 987-1000
34. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
35. Day C.P. Non-alcoholic steatohepatitis (NASH): where are we now and where are we going?. Gut 50 (2002) 585-588
36. Manton N.D., Lipsett J., Moore D.J., Davidson G.P., Bourne A.J., and Couper R.T. Non-alcoholic steatohepatitis in children and adolescents. Med J 173 9 (2000) 476-479
37. Fishbein M., Mogren J., Mogren C., et al. Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease. Clin Pediatr (Phila) 44 (2005) 135-141
38. Rashid M., and Roberts E.A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30 1 (2000) 48-53
39. Willner I.R., Waters B., Patil S.R., et al. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 (2001) 2957-2961
40. Rashid M., and Roberts E.A. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 30 (1995) 48-53
41. Siegelman E.S., and Rosen M.A. Imaging of hepatic steatosis. Semin Liver Dis 21 (2001) 71-80
42. Duman D.G., Celikel C., Tuney D., et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment?. Digest Dis Sci 51 (2006) 346-351
43. Reid A.E. Nonalcoholic steatohepatitis. Gastroenterology 121 (2001) 710-723
44. Dixon J.B., Bhathal P.S., Hughes N.R., and O'Brien P.E. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39 (2004) 1647-1654
45. Park H.S., Kim M.W., and Shin E.S. Effect of weight control on hepatic abnormalyties in obese patients with fatty liver. J Korean Med Sci 10 (1995) 414-421
46. Ueno T., Sugawara H., Sujaku K., et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 27 (1997) 103-107
47. Andersen T., Gluud C., Franzmann M.B., and Christoffersen P. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12 (1991) 224-229
48. Tock L., Prado W.L., Caranti D.A., et al. Non-alcoholic fatty liver disease in obese adolescents after multidisciplinary therapy. Eur J Gastroenterol Hepatol 18 12 (2006) 1241-1245
49. Dufour J.F., Oneta C.M., Gonvers J.J., et al. Randomized placebo controlled trial of ursodeoxycholic acid with vitamin e in non-alcoholic steatohepatitis. Clin Gastroenterol Hepatol 4 12 (2006) 1537-1543
50. Harrison S.A., Torgerson S., Hayashi P., et al. Vitamin E and vitamin C treatment improve fibrosis in patients with non-alcoholic steatohepatitis. Am J Gastroenterol 98 (2003) 2348-2350
51. Lavine J.E. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 136 6 (2000) 734-738
52. Vajro P., Mandato C., Franzese A., et al. Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. J Pediatr Gastroenterol Nutr 38 1 (2004) 48-55
53. Lavine J.E., and Schwimmer J.B. Clinical research network launches TONIC trial for treatment of non-alcoholic fatty liver disease in children. J Pediatr Gastroenterol Nutr 42 (2006) 129-130
54. Abdelmalek M.F., Angulo P., Jorgensen R.A., et al. Betaine, a promising new agent for patients with non-alcoholic steatohepatitis: results of a pilot study. Am J Gasrtoenterol 96 (2001) 2711-2717
55. Lindor K.D., Kowdley K.V., Heathcote E.J., et al. Ursodeoxycholic acid for treatment of non-alcoholic steatohepatitis: results of a randomized trial. Hepatology 39 (2004) 770-778
56. Vajro P., Franzese A., Vlerio G., et al. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr 136 (2000) 739-743
57. Bugianesi E., Gentilcore E., Manini R., et al. A randomized controlled trial of metformin versus Vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastronterol 100 (2005) 1082-1090
58. Marchesini G., Brizi M., Bianchi G., et al. Metformin in nonalcoholic steatohepatitis. Lancet 358 (2001) 893-894
59. Schwimmer J.B., Middleton M.S., Deutsch R., et al. A phase 2 clinical trial of metformin as a treatment for non-diabetic pediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 21 (2005) 871-879
60. Basaranoglou M., Acbay O., and Sonzun A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatology 31 (1999) 384
61. Levy J.R., Clore J.N., and Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fisher 344 rats. Hepatology 39 (2004) 608-616